NXTC - NextCure  - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

NXTC is currently covered by 2 analysts with an average price target of $-46.67. This is a potential upside of $-59.27 (-470.4%) from yesterday's end of day stock price of $12.6.

NextCure 's activity chart (see below) currently has 32 price targets and 36 ratings on display. The stock rating distribution of NXTC is 100% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 93.51% with an average time for these price targets to be met of 379.13 days.

Highest price target for NXTC is $15, Lowest price target is $3, average price target is $9.

Most recent stock forecast was given by EDWARD TENTHOFF from PIPER SANDLER on 15-Jul-2025. First documented stock forecast 03-Jun-2019.

Currently out of the existing stock ratings of NXTC, 5 are a BUY (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy

$15

$2.4 (19.05%)

$13

3 months 18 days ago
(15-Jul-2025)

10/11 (90.91%)

$10.24 (215.13%)

507

Buy

$3

$-9.6 (-76.19%)

$3

4 months 1 days ago
(01-Jul-2025)

4/7 (57.14%)

$-2.23 (-42.64%)

336

Buy

$4

$-8.6 (-68.25%)

$4

1 years 3 months ago
(02-Aug-2024)

7/7 (100%)

$-15.2 (-79.17%)

522

Hold

$16

2 years 11 months 29 days ago
(04-Nov-2022)

1/1 (100%)

$-43.04 (-72.90%)

273

Buy

$15

$2.4 (19.05%)

3 years 2 months 10 days ago
(23-Aug-2022)

2/2 (100%)

$-38.28 (-71.85%)

302

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is NXTC (NextCure ) average time for price targets to be met?

On average it took 379.13 days on average for the stock forecasts to be realized with a an average price target met ratio 93.51

Which analyst has the current highest performing score on NXTC (NextCure ) with a proven track record?

EDWARD TENTHOFF

Which analyst has the current lower performing score on NXTC (NextCure ) with a proven track record?

AYDIN HUSEYNOV

Which analyst has the most public recommendations on NXTC (NextCure )?

Edward Tenthoff works at PIPER SANDLER and has 5 price targets and 4 ratings on NXTC

Which analyst is the currently most bullish on NXTC (NextCure )?

Jeffrey Hung with highest potential upside - $5.3

Which analyst is the currently most reserved on NXTC (NextCure )?

Emily Bodnar with lowest potential downside - -$9.6

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?